atopic dermatiits
Showing 1 - 25 of 1,225
Atopic Dermatitis Trial in Culver City (Ruxolitinib cream, Vehicle)
Recruiting
- Atopic Dermatitis
- Ruxolitinib cream
- Vehicle
-
Culver City, CaliforniaScience37
Jan 12, 2023
Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)
Not yet recruiting
- Atopic Dermatitis
- Baricitinib 4 MG
- Azathioprine 1.5-2.5 mg/kg
-
Sari, Mazandaran, Iran, Islamic Republic ofIran
Aug 1, 2023
Atopic Dermatitis Trial (Cosmetic Product TOPIALYSE Baume Protect+)
Not yet recruiting
- Atopic Dermatitis
- Cosmetic Product TOPIALYSE Baume Protect+
- (no location specified)
Oct 25, 2023
Moderate to Severe Atopic Dermatitis Trial (SHR-1819 injection)
Not yet recruiting
- Moderate to Severe Atopic Dermatitis
- SHR-1819 injection
- (no location specified)
Aug 22, 2023
Atopic Dermatitis Trial in Canada, United States (Oral EP262, Placebo)
Recruiting
- Atopic Dermatitis
- Oral EP262
- Placebo
-
Birmingham, Alabama
- +9 more
Nov 28, 2023
Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)
Completed
- Cutaneous Nerves CNS Itch
-
Minneapolis, MinnesotaUniversity of Minnesota Department of Dermatology
Jan 23, 2023
Dermatitis, Atopic Trial in High Point (Gel Cream)
Completed
- Dermatitis, Atopic
- Gel Cream
-
High Point, North CarolinaDermatology Consulting Services, PLLC
Nov 4, 2022
Atopic Dermatitis Trial in Roma (Upadacitinib)
Recruiting
- Atopic Dermatitis
- Upadacitinib
-
Roma, ItalyIrccs Fondazione Policlinico Gemelli
Aug 4, 2023
Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)
Recruiting
- Atopic Dermatitis
- GD-iExo-001
- normal saline
-
Beijing, Beijing, ChinaChinese Academy of Medical Science & Peking Union Medical Colleg
Jul 23, 2023
Dupilumab in Participants =6 Years With Atopic Dermatitis
Recruiting
- Atopic Dermatitis
-
Berlin, GermanyInvestigational Site Number :
Sep 18, 2023
Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)
Recruiting
- Atopic Dermatitis
- UCB1381
- Placebo
-
Glendale, CaliforniaUp0110 101
Jan 20, 2023
Atopic Dermatitis Trial in Shenyang, Jinan (1.5% QLM3003, 2% QLM3003, Vehicle (Placebo))
Not yet recruiting
- Atopic Dermatitis
- 1.5% QLM3003
- +2 more
-
Shenyang, Liaoning, China
- +1 more
Sep 21, 2023
Atopic Dermatitis Trial in Shanghai (MG-K10/Placebo)
Active, not recruiting
- Atopic Dermatitis
- MG-K10/Placebo
-
Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Aug 31, 2023
Atopic Dermatitis Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
Insulin Resistance in Atopic Dermatitis Patients
Recruiting
- Atopic Dermatitis
-
Istanbul, TurkeyBezmialem Vakif University Hospital
Jun 6, 2023
Atopic Dermatitis Eczema Trial in Columbus (Arctiva)
Completed
- Atopic Dermatitis Eczema
- Arctiva
-
Columbus, OhioClinOhio Research Services, LLC
Jun 23, 2023
Psoriasis, Atopic Dermatitis Trial in United States (XmAb27564, Placebo)
Recruiting
- Psoriasis
- Atopic Dermatitis
- XmAb27564
- Placebo
-
Thousand Oaks, California
- +3 more
Aug 22, 2023
Effects of Abrocitinib Treatment on Skin Barrier Function
Recruiting
- Atopic Dermatitis
- No Intervention
-
Kiel, Schleswig-Holstein, GermanyUKSH, Campus Kiel
Dec 28, 2022
Natural History of Severe Allergic Inflammation and Reactions
Recruiting
- PGM3 Deficiency
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Atopic Dermatitis Trial (CM310)
Not yet recruiting
- Atopic Dermatitis
- CM310
- (no location specified)
Oct 30, 2023
Hidradenitis Suppurativa, Atopic Dermatitis, Healthy Volunteer Trial (LT-002-158/Placebo oral tablet(s))
Not yet recruiting
- Hidradenitis Suppurativa
- +2 more
- LT-002-158/Placebo oral tablet(s)
- (no location specified)
Oct 9, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)
Not yet recruiting
- Atopic Dermatitis
- +2 more
- HY209GEL Active
- Placebo
- (no location specified)
Aug 31, 2023